Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
about
Therapeutic cancer vaccines: past, present, and futureImmunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.The Goldilocks model for TCR-too much attraction might not be best for vaccine designEnrichment and detection of peptides from biological systems using designed periodic mesoporous organosilica microspheres.Translating tumor antigens into cancer vaccinesImproving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses.Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.Improving T cell responses to modified peptides in tumor vaccinesBasic and translational applications of engineered MHC class I proteins.Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell ResponsesIdentification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen.Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model.Enhanced antitumor effects of a dendritic cell vaccine transfected with gastric cancer cell total RNA carrying the 4-1BBL gene in vitro.Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis.
P2860
Q26863283-EFD8E2D5-FADD-4293-9E0B-F71A6D0CA2BFQ33556731-1651B83D-D368-4867-B422-15390E22E9A4Q33698006-CB3DB2FF-2AE6-446C-BA06-EB0B84160288Q34089146-175FD332-2BF3-45F0-9AD9-F5D2757FF370Q34484042-E573D40C-8FC9-4C56-AF8F-F31A9DDA6EDEQ35012363-E8E19082-BB58-42ED-B579-BE834274F676Q35906719-02BEF792-B4FD-43D3-8647-759AA916AEDDQ36050577-89350F5D-885C-4FC0-A034-DF5F83432082Q36137249-955DBC6D-56F1-44CF-9176-20DA9316045DQ36166566-DA455221-6324-4323-A359-5B610DEFCD25Q36510860-6B6FBD46-13AB-4111-BCC7-0398A91A7351Q37634253-B800FA3F-08F3-416D-A53F-A375FC5A7263Q37787436-C46764CF-73DC-4176-B664-C49708DAD037Q38582086-63C5B98B-7794-4172-9894-336D25A2F399Q39290116-E4C7985B-6278-40A3-A915-24D1B8D3AF6BQ39637191-87A155F5-0ED7-42C3-B291-16B5C5D86B6CQ41903166-2F8919DE-9C7A-445B-BD9D-1A2A636C9DF5Q52777949-95DD8B59-6A36-4583-87AD-0299E7371FF5
P2860
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@ast
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@en
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@nl
type
label
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@ast
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@en
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@nl
prefLabel
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@ast
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@en
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@nl
P2093
P2860
P356
P1476
Peptide vaccines prevent tumor ...... pond to native tumor antigens.
@en
P2093
Charles B Kemmler
Jill E Slansky
Kimberly R Jordan
Rachel H McMahan
P2860
P304
P356
10.1073/PNAS.0914879107
P407
P50
P577
2010-01-26T00:00:00Z